Physician profile
Roman B Malley
NPI 1083655443
$21,446.76
in general payments reported to CMS, 2019-2025
74 companies · $4,592 in 2025
The $4,592 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,922 · 2020: $1,834 · 2021: $3,463 · 2022: $2,784 · 2023: $1,926 · 2024: $2,925 · 2025: $4,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,443.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $4,750.11 | 2019-2025 | Evenity, Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,740.68 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $1,595.47 | 2019-2025 | |
| Lilly USA, LLC | $1,089.02 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $740.55 | 2019-2025 | Ofev, Jardiance, Synjardy |
| Esperion Therapeutics, INC. | $718.59 | 2020-2025 | Nexletol, Nexlizet |
| Novo Nordisk INC | $687.83 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $629.51 | 2019-2025 | |
| Glaxosmithkline, LLC. | $571.33 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $494.22 | 2019-2022 | |
| Abbott Laboratories | $491.08 | 2019-2025 | Freestyle Libre 3 |
| Neurocrine Biosciences, INC. | $485.47 | 2019-2025 | Ingrezza |
| Sanofi-Aventis U.S. LLC | $427.03 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $425.42 | 2019-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $404.54 | 2021-2025 |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $401.14 | 2019-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $370.78 | 2019-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $285.93 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $280.77 | 2019-2025 | Gardasil 9, Capvaxive, Belsomra |
| Amarin Pharma, INC. | $266.93 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $246.33 | 2019-2023 | Eliquis |
| Incyte Corporation | $244.78 | 2022-2024 | Opzelura |
| Radius Health, INC. | $244.35 | 2025 | Tymlos |
| Allergan, INC. | $224.67 | 2019-2020 | |
| Lupin INC. | $198.67 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $190.76 | 2021 | |
| Lundbeck LLC | $190.64 | 2023-2025 | Rexulti, Vyepti |
| Ardelyx, INC. | $180.84 | 2024-2025 | Ibsrela |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $172.39 | 2025 | Caplyta |
| Teleflex LLC | $171.97 | 2025 | Urolift |
| Kowa Pharmaceuticals America, INC. | $166.34 | 2022-2025 | Zoryve |
| Eisai INC. | $166.19 | 2020-2025 | |
| Alkermes, INC. | $165.21 | 2021-2025 | Aristada, Lybalvi |
| Phathom Pharmaceuticals, INC. | $157.67 | 2024-2025 | Voquezna |
| Ironwood Pharmaceuticals, INC | $135.39 | 2020-2022 | |
| Abiomed | $132.61 | 2024-2025 | Impella |
| Genentech USA, INC. | $130.00 | 2020 | |
| Dynavax Technologies Corporation | $122.81 | 2020-2025 | Heplisav-B |
| Teva Pharmaceuticals USA, INC. | $121.84 | 2025 | Austedo Xr |
| Sanofi Pasteur INC. | $109.67 | 2019-2025 | |
| Philips North America LLC | $88.39 | 2019 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $86.64 | 2023-2025 | Rexulti |
| Boston Scientific Corporation | $69.32 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Alnylam Pharmaceuticals INC. | $54.81 | 2025 | Amvuttra |
| Aimmune Therapeutics, INC. | $53.99 | 2024 | |
| Alexion Pharmaceuticals, INC. | $50.23 | 2022 | |
| Exact Sciences Corporation | $50.10 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ucb, INC. | $46.28 | 2021-2025 | Fintepla |
| Biosense Webster, INC. | $44.45 | 2024 | Qdot Micro Catheter |
| Medtronic, INC. | $37.74 | 2023 | Intellis Adaptivestim |
| Urovant Sciences INC | $31.68 | 2022 | |
| Seqirus USA INC | $31.31 | 2024-2025 | Fluad, Flucelvax |
| Nevro Corp. | $31.26 | 2022 | |
| Intercept Pharmaceuticals, INC. | $30.00 | 2023 | Ocaliva |
| Shionogi INC | $29.61 | 2020 | |
| Idorsia Pharmaceuticals US INC | $28.19 | 2023-2024 | Quviviq |
| Mannkind Corporation | $27.18 | 2025 | |
| Biogen, INC. | $25.30 | 2025 | Leqembi |
| Hologic Sales and Service, LLC | $24.67 | 2025 | Thinprep 2000 Processor, Aptima |
| Corcept Therapeutics | $23.48 | 2020 | |
| Shield Therapeutics INC | $22.74 | 2023 | Accrufer |
| Biocryst US Sales Co., LLC | $21.99 | 2021 | |
| Vertos Medical, INC. | $21.18 | 2022 | |
| Scpharmaceuticals INC. | $20.72 | 2024 | |
| Daiichi Sankyo INC. | $20.20 | 2024 | Injectafer |
| Sun Pharmaceutical Industries INC. | $19.39 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.10 | 2022 | |
| Assertio Therapeutics, INC. | $18.03 | 2020 | |
| Acadia Pharmaceuticals INC | $16.35 | 2021 | |
| Medtronic USA, INC. | $16.30 | 2020 | |
| Dexcom, INC. | $15.87 | 2024 | Dexcom G6 Transmitter |
| Vertiflex, INC. | $14.97 | 2019 | |
| Avanir Pharmaceuticals, INC. | $14.08 | 2021 | |
| Horizon Therapeutics Plc | $11.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Malley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.